Study: Preoperative estrogen-blocking therapy may preempt need for mastectomy
Orlando – March 23, 2012. Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according to the results of a national clinical trial presented today at the Society of Surgical Oncology annual meeting in Orlando, Fla.
"We found that half of the postmenopausal women in the study who initially faced having a mastectomy were able to have breast-conserving surgery after being treated for four months with an aromatase ...










